Today: 7 February 2026
Subscribe

Silver ETF SLV slides as silver tumbles from $83 record high

Silver ETF SLV slides as silver tumbles from $83 record high

NEW YORK, December 29, 2025, 14:35 ET — Regular session Shares of iShares Silver Trust (SLV) fell about 8.6% to $65.01 in afternoon trading on Monday, tracking a sharp reversal in silver after the metal briefly surged to a fresh record above $83 an ounce. The physically backed exchange-traded fund is designed to follow the LBMA Silver Price benchmark. Reuters+1 The move matters because silver is up about 150% this year, leaving positioning vulnerable as investors square books into year-end. When the metal swings, losses can quickly spill into silver-linked funds and mining shares. Reuters Traders cited profit-taking after the
29 December 2025
·····
Aura Minerals stock slides nearly 9% as gold pullback and margin hike hit miners

Aura Minerals stock slides nearly 9% as gold pullback and margin hike hit miners

NEW YORK, December 29, 2025, 14:36 ET — Regular session Aura Minerals Inc shares fell 8.9% to $49.26 on Monday afternoon, giving back earlier gains as gold-linked equities sold off with bullion. The move matters because miners often act like a levered bet on metals: sharp swings in gold and silver can translate quickly into bigger moves in mining stocks. Monday’s drop also comes amid thin year-end liquidity, which can amplify price moves. Aura’s stock traded in a wide range, touching $54.90 at the session high before sliding to around $49.20 at the low. Volume was about 641,000 shares. The
29 December 2025
·····
Carvana slips in thin year-end trade as Wall Street pares risk

Carvana slips in thin year-end trade as Wall Street pares risk

NEW YORK, December 29, 2025, 13:51 ET — Regular session Shares of Carvana Co. (CVNA) were down about 0.6% at $436.00 in afternoon trading on Monday, giving back early gains in a quiet, year-end market. The pullback comes after a bruising run in 2025. Carvana has returned about 116% year-to-date on a total-return basis, according to Total Real Returns, leaving the stock sensitive to small shifts in risk appetite. That sensitivity is in focus as the market heads into the final trading days of the year. Many money managers rebalance portfolios in late December, and high-momentum names can swing sharply
29 December 2025
·····
JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

NEW YORK, December 29, 2025, 14:38 ET — Regular session Johnson & Johnson shares were up about 0.3% at $208.28 in afternoon trading on Monday after the healthcare conglomerate said it had completed its $3.05 billion cash acquisition of Halda Therapeutics. JNJ.com The close matters because it brings Johnson & Johnson a clinical-stage oncology platform and assets as investors press large drugmakers to keep replenishing their pipelines ahead of patent expirations and pricing pressure. It also puts the focus back on execution: the deal is expected to dent near-term profit metrics, and Johnson & Johnson has flagged its next earnings
29 December 2025
·····
Sibanye Stillwater drops as gold, platinum retreat from record highs

Sibanye Stillwater drops as gold, platinum retreat from record highs

NEW YORK, December 29, 2025, 14:30 ET — Regular session. Sibanye Stillwater Limited’s U.S.-listed ADRs fell 9.4% to $14.22 in afternoon trading on Monday, as a sharp pullback in precious metals knocked mining shares lower. The stock has traded between $14.06 and $15.24 so far, with about 7.2 million shares changing hands. The move matters because bullion — precious metals such as gold — has been the market’s momentum trade into year-end, and miners have been priced for higher realized metal prices. Monday’s reversal shows how quickly that bet can unwind when traders lock in gains. Sibanye is highly geared
29 December 2025
·····
Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

NEW YORK, December 29, 2025, 14:15 ET — Regular session Bristol Myers Squibb shares fell on Monday, with the drugmaker lagging a slightly weaker U.S. stock market in holiday-thinned trading. The stock was down 0.7% at $54.27 in afternoon trade. The move matters now because the final week of the year often brings abrupt swings on light volume, even when company-specific headlines are scarce. Bristol Myers is also approaching two calendar catalysts that can influence positioning: its next dividend record date and its next earnings report. U.S. stocks eased from record highs at the start of a holiday-shortened week, and
29 December 2025
·····
Ondas stock wobbles on heavy volume as a January share issuance nears

Ondas stock wobbles on heavy volume as a January share issuance nears

NEW YORK, December 29, 2025, 2:33 PM ET — Regular session Shares of Ondas Holdings Inc were down about 0.5% at $8.44 in Monday afternoon trading, sliding with a broader pullback in drone and defense-tech names. The dip comes as investors size up an early-January stock issuance tied to a recent exchange deal that increased the number of shares available for resale in the market. Ondas Holdings Inc.+1 It also lands days before year-end results will absorb an accounting hit. Ondas said it expects a one-time, non-cash charge of about $56.6 million in the quarter ending Dec. 31 — an
29 December 2025
···
NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

NEW YORK, December 29, 2025, 14:07 ET — Regular session Nebius Group N.V. shares fell on Monday after a filing showed founder and CEO Arkady Volozh intends to sell a small portion of his stake. The timing matters because NBIS has become a high-volatility proxy for investor appetite for AI data-center capacity, and year-end trading can amplify price swings. Google Finance data shows the stock has ranged from about $18 to $141 over the past 52 weeks, with a market value around $21.7 billion. Google The broader AI trade also cooled. Wall Street’s main indexes opened the final trading week
29 December 2025
·····
Uber stock steadies in late-2025 market wobble as traders watch the next catalyst

Uber stock steadies in late-2025 market wobble as traders watch the next catalyst

NEW YORK, December 29, 2025, 14:09 ET — Regular session. Uber Technologies Inc. shares edged up 0.1% to $81.38 in afternoon trading on Monday, bucking a softer tape in the final week of the year. The stock traded between $80.61 and $82.19. The muted move matters now because liquidity is thin and many investors are rebalancing into year-end, making single-stock moves more sensitive to macro swings and sector rotation. For Uber, that backdrop comes as traders look for clarity on holiday-quarter demand and the legal headlines hanging over its subscription business. On Wall Street, the S&P 500 and Nasdaq were
29 December 2025
····
BellRing Brands stock slides about 9% as legal probe notice hits and volatility returns

BellRing Brands stock slides about 9% as legal probe notice hits and volatility returns

NEW YORK, December 29, 2025, 14:32 ET — Regular session BellRing Brands Inc (BRBR.N) shares were down $2.83, or 9.4%, at $27.33 by 2:32 p.m. ET, after opening at $30.15 and sliding to a session low of $26.66. The stock last traded as high as $30.20, with volume around 2.9 million shares. The drop matters because investors have been quick to punish any fresh uncertainty around the protein-shake maker’s near-term sales trajectory and margins. BellRing is coming off a year in which sentiment swung sharply on questions about whether shipments are matching consumer demand. In November, BellRing forecast fiscal 2026
29 December 2025
·····
Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

NEW YORK, December 29, 2025, 2:08 PM ET — Regular session Pfizer shares dipped slightly on Monday, trading down about 0.1% at $25.06 as of 2:08 p.m. ET. The stock has moved between $24.99 and $25.19 in the regular session. The muted move matters because liquidity is thinning into year-end, leaving defensive names like large drugmakers more sensitive to sector headlines and positioning. Reuters reported trading volumes were expected to be light this week, with U.S. markets shut on Thursday for New Year’s Day. Reuters For Pfizer, the backdrop is still its long-dated reset story: investors are weighing whether its
29 December 2025
·····
Newmont tumbles as gold drops 4% and CME hikes metals margins

Newmont tumbles as gold drops 4% and CME hikes metals margins

NEW YORK, December 29, 2025, 14:25 ET — Regular session Shares of Newmont (NEM) fell 5.7% to $99.70 in afternoon trading, leading declines in major gold miners as gold prices slid more than 4% from record highs and traders unwound positions. The move matters because gold’s year-end surge has been one of 2025’s standout trades, pulling miners and precious-metals funds higher with it. A sharp reversal can force fast selling in a market that is already thin after the holidays. It also lands just as exchanges raise collateral demands, a common volatility brake that can push leveraged traders to cut
29 December 2025
········
1 … 1,115 1,116 1,117 1,118 1,119 … 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop